Regulatory Information

MedX SIAscopy

MedX is committed to technology that is safe and effective.

The safety and effectiveness for patients is our first priority. SIAcopy is rapid, patient friendly, accurate, easy to use, and practice friendly. SIAscopy has been used for over 12 years and is supported by over 15 published clinical studies and 24 in vivo clinical posters. MedX Health designs, develops and distributes innovative imaging and software technologies that have been evaluated and tested for safety and effectiveness and cleared and licensed for use in Canada, United States, European Union, Australia and New Zealand.

The technology has gone through stringent evaluation and testing and it has been cleared for sale by the following regulatory bodies: Health Canada, US-FDA, Australia TGA, New Zealand Medsafe and an EU-designated Notified Body for medical devices.